Moderní imunoterapie a genová terapie

Přednášející

Blok 1 Fundamentals in immunology and therapy

9:00Heinrich Haas
BioNTech RNA Pharmaceuticals GmbH, An der Goldgrube 12, D-55131 Mainz, Germany
Bude zveřejněno

9:25 Daniel Scherman
Director of CNRS, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS)
Université Paris Descartes – Chimie ParisTech, CNRS UMR8258-U1022 Inserm, France
New development in plasmid optimization for gene therapy and vaccines

9:50 Lei Fu
Laboratory of Medicinal Chemistry & Integrative Medicine, School of Pharmacy, Shanghai Jiao Tong University,800 Dongchuan Road, Shanghai, 200240, P.R.China
Introducing School of Pharmacy and my research on Cytochrome c Oxidase Inhibitiors in Shanghai Jiao Tong University

Break 10:15 – 10:45
Blok 2 Fundamental tools to probe and to understand biological mechanisms

10:45 Jan Krejsek
Head of the Department of Clinical Immunology and Allergology, Faculty of Medicine Charles University in Hradec Králové, Simkova 870, 500 03 Hradec Kralove, Czech Republic
Sterilní zánět, alarminy a princip mechachanismu adjuvans
Sterilní zánět, princip mechanismu adjuvans Al(OH)3


11:10 Nicole Meisner-Kober
Novartis Institutes for Biomedical Research, CH-4000 Basel, Switzerland
Cell entry routes of exosomes as a novel paradigm for therapeutic RNA and drug delivery


11:35Hana Španielová
Katedra genetiky a mikrobiologie, Přírodovědecká fakulta, Univerzita Karlova
Přírodovědecká fakulta, Viničná 5, 128 43 Praha 2, Czech Republic [TRANSLATE]
VirPorters

Oběd 12:00 – 13:30

Blok 3 Creating key technologies for therapy

13:30 Régis Tournebize
Imagopole et INSERM 1202, Institute Pasteur,25-28 Rue du Dr Roux, 75015 Paris, France
Bude zveřejněno

13:55 Nigel Temperton
Head of Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent at Medway, Anson Building, Central Avenue, Chatham, Maritime, Chatham, Kent, ME4 4TB, United Kingdom
Bude zveřejněno

Break 13:55 – 14:30

Blok 4 Translating breakthrough technologies for therapy to the clinic

14:30 Jeffrey Ulmer
Head of Preclinical R&D US, GlaxoSmithKline Vaccines,14200 Shady Grove Rd, Rockville, MD 20850, USA
Vaccine technologies for the discovery and development of new vaccines

14:55Petr Malý
Head of the Laboratory of Ligand Engineering, Institute of Molecular Genetics of the Czech Academy of Sciences,v. v. i.,Vídeňská 1083, 142 20 Prague 4, Czech Republic
Bude zveřejněno



Konec 15:20